CA Stock MarketDetailed Quotes
Vector Science and Therapeutics Corp (PAIN)
- 2.320
- -0.030-1.28%
15min DelayMarket Closed Jul 10 16:00 ET
12.76MMarket Cap-4.84P/E (TTM)
2.350High2.230Low406.18KVolume2.350Open2.350Prev Close924.08KTurnover2.65052wk High7.39%Turnover Ratio5.50MShares0.35052wk Low-0.479EPS TTM12.76MFloat Cap2.650Historical HighLossP/E (Static)5.50MShs Float0.350Historical Low-0.224EPS LYR5.11%Range %--Dividend TTM12.61P/B1Lot Size--Div Yield TTM
PAIN Stock Chart
Intraday
- 5D
- Daily
- Weekly
- Monthly
- 1Q
- 1Y
PAIN Orderflow
Unit: --
PAIN Orderflow Trend
IntradayDayWeekMonth
No Data
Vector Science and Therapeutics Corp (PAIN) News
Vector Science & Therapeutics Announces Landmark Exclusive CGMP Manufacturing Agreement With LyoGenesis Plus for Its Proprietary Peptide Portfolio
Vector Science & Therapeutics Files Provisional Patent for Breakthrough Transdermal Peptide Delivery Platform
Vector Science & Therapeutics Names Dexter Fowler as Chief Athletic Officer for Its Valor Platform
Vector Science & Therapeutics Appoints Darryl Drake Jr. as Pres of Valor
Vector Science & Therapeutics Corp. Grants Options as Company Advances Growth Strategy
Press Release: Vector Science & Therapeutics Agrees to an Option to Invest in LyoGenesis Plus, Securing Long-Term Access to FDA-Registered, CGMP Manufacturing